Adrafinil (Olmifon)
Adrafinil (Olmifon) is part of a family of drugs called "eugeroics",
meaning "good arousal". It is a mild stimulant to the central nervous system
that is used to relieve excessive day time sleepiness and lack of concentration
and attention in elderly patients. It promotes vigilance and alertness by
enhancing the chemical processes within the brain without affecting heart rate
or pressure, and does not affect normal sleep patterns.
How Does Adrafinil Work?
Adrafinil (Olmifon) was discovered in the late 1970s through association with
the French pharmaceutical company Group Lafon. The drug was first presented as
an experimental treatment for narcolepsy in France in 1986 and has since been
approved in many European countries for treating this condition.
In comparison with other familiar stimulants, such as caffeine or
methamphetamine, Adrafinil (Olmifon) is considered gentler because it does not
result in the anxiety, agitation and insomnia associated with these conventional
stimulants. Of particular interest is its unique ability to only arouse when
stimulation is required.
Based on its ability to selectively stimulate adrenergic brain receptors,
Adrafinil (Olmifon) builds slowly over a period of days and months. These
receptors normally respond to norepinephrine (noradrenaline), a neurotransmitter
that is linked to alertness, learning, and memory. In contrast, conventional
stimulants, access a broader spectrum of brain receptors, including those
involving dopamine.
Other Benefits of Adrafinil
Adrafinil (Olmifon) is also beneficial to non-narcoleptic users. It is found to
increase energy and reduce fatigue while positively impacting cognitive
function, mental clarity, concentration and general memory. It has been reported
that, following use, quiet people become more talkative, reserved people tend to
become more open, and passive people become more active.
Current product details